These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15605672)

  • 1. Disseminated tuberculosis complicating anti-TNF-alpha treatment.
    Dimakou K; Papaioannides D; Latsi P; Katsimboula S; Korantzopoulos P; Orphanidou D
    Int J Clin Pract; 2004 Nov; 58(11):1052-5. PubMed ID: 15605672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment.
    Mayordomo L; Marenco JL; Gomez-Mateos J; Rejon E
    Scand J Rheumatol; 2002; 31(1):44-5. PubMed ID: 11922200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult diagnosis of infliximab-related miliary tuberculosis.
    Contini S; Raimondi G; Graziano P; Saltini C; Bocchino M
    Monaldi Arch Chest Dis; 2004; 61(2):128-30. PubMed ID: 15510715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases].
    Roth S; Delmont E; Heudier P; Kaphan R; Cua E; Castela J; Verdier JM; Chichmanian RM; Fuzibet JG
    Rev Med Interne; 2002 Mar; 23(3):312-6. PubMed ID: 11928379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miliary nodularity in a patient receiving TNF inhibitors is not always miliary tuberculosis.
    Haroon M; Cushen B; Veale D
    J Rheumatol; 2012 Mar; 39(3):651-2. PubMed ID: 22383353
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
    Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
    Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF treatment and miliary tuberculosis in Crohn's disease.
    Milenković B; Dudvarski-Ilić A; Janković G; Martinović L; Mijac D
    Srp Arh Celok Lek; 2011; 139(7-8):514-7. PubMed ID: 21980664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
    Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S
    Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis.
    Jung N; Owczarczyk K; Hellmann M; Lehmann C; Fätkenheuer G; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):932-3. PubMed ID: 18417524
    [No Abstract]   [Full Text] [Related]  

  • 12. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.
    Kroesen S; Widmer AF; Tyndall A; Hasler P
    Rheumatology (Oxford); 2003 May; 42(5):617-21. PubMed ID: 12709536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report.
    Muñoz-Oca JE; Villarreal Morales ML; Nieves-Rodriguez A; Martínez-Bonilla L
    BMC Infect Dis; 2017 Jan; 17(1):70. PubMed ID: 28086756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non tuberculous anti-TNF associated opportunistic infections].
    Marie I; Guglielmino E
    Rev Med Interne; 2010 May; 31(5):353-60. PubMed ID: 20381217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The yin and yang of tumor necrosis factor inhibitors.
    Calabrese L
    Cleve Clin J Med; 2006 Mar; 73(3):251-6. PubMed ID: 16548447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?
    Giardina AR; Accardo-Palumbo A; Ciccia F; Ferrante A; Principato A; Impastato R; Triolo G
    Reumatismo; 2009; 61(1):21-6. PubMed ID: 19370184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    Keane J; Gershon S; Wise RP; Mirabile-Levens E; Kasznica J; Schwieterman WD; Siegel JN; Braun MM
    N Engl J Med; 2001 Oct; 345(15):1098-104. PubMed ID: 11596589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
    Amano K
    Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disseminated tuberculosis in patient with rheumatoid arthritis after infliximab therapy].
    Ramos González A; Corzo Delgado JE; Sánchez Bursón J
    Med Clin (Barc); 2002 Nov; 119(16):636-7. PubMed ID: 12433341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.